{"id":"W2590667995","doi":"10.1200/jco.2012.30.15_suppl.e14176","title":"Clinical benefit rate (CBR) of panitumumab monotherapy among patients with KRAS wild-type metastatic colorectal cancer (mCRC).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Irinotecan; Oxaliplatin; Panitumumab; Bevacizumab; Internal medicine; Clinical endpoint; KRAS; Colorectal cancer; Capecitabine; Oncology; Response Evaluation Criteria in Solid Tumors; Cetuximab; Tolerability; Phases of clinical research; Gastroenterology; Cancer; Clinical trial; Chemotherapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002019042,0.0003029413,0.001011578,0.000294735,0.0001142316,0.0004300862,0.0001857186,0.0005130982,0.001930731],"category_scores_gemma":[0.002152606,0.0001668291,0.0007919479,0.0002502011,0.0001537479,0.000372079,0.0003163392,0.0008122706,0.0003248007],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003968585,"about_ca_system_score_gemma":0.0002088437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002155031,"about_ca_topic_score_gemma":0.0003497129,"domain_scores_codex":[0.9995067,0.0002643469,0.00003961826,0.00007208662,0.00006588302,0.00005124481],"domain_scores_gemma":[0.9989699,0.0004094633,0.0003294857,0.00004954345,0.00003763899,0.0002039866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5422596,0.006210174,0.2183183,0.0008213585,0.003164152,0.0007342255,0.0001602489,0.003892393,0.02272193,0.0002264467,0.002051687,0.1994395],"study_design_scores_gemma":[0.05936621,0.2408724,0.6740508,0.0001031445,0.003659126,0.002505342,0.00009435317,0.006444473,0.007535264,0.0003784413,0.004926426,0.0000641096],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996205,0.00218143,0.0001526536,0.0001513472,0.00002318461,0.00008991193,0.0003180555,0.00001253044,0.0008658756],"genre_scores_gemma":[0.9984267,0.0004156422,0.0001296835,0.000102103,0.00003988877,0.00004773155,0.0004693809,0.000003432335,0.0003655284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002019042,"threshold_uncertainty_score":0.01067787,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09966892773303992,"score_gpt":0.4553142123894501,"score_spread":0.3556452846564102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}